Education
About Us
Working with TipRanks
Follow Us
Procter & Gamble Health Ltd. (IN:PGHL)
:PGHL
RESEARCH TOOLSreports
Total Valuation
Procter & Gamble Health Ltd. has a market cap or net worth of ₹105.29B. The enterprise value is ₹0.00.
Market Cap₹105.29B
Enterprise Value₹0.00
Share Statistics
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,599,382
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Procter & Gamble Health Ltd.’s return on equity (ROE) is 0.58 and return on invested capital (ROIC) is 52.02%.
Return on Equity (ROE)0.58
Return on Assets (ROA)0.39
Return on Invested Capital (ROIC)52.02%
Return on Capital Employed (ROCE)0.69
Revenue Per Employee9.32M
Profits Per Employee2.34M
Employee Count1,336
Asset Turnover1.57
Inventory Turnover5.14
Valuation Ratios
The current PE Ratio of Procter & Gamble Health Ltd. is 35.0. Procter & Gamble Health Ltd.’s PEG ratio is ―.
PE Ratio35.0
PS Ratio―
PB Ratio―
Price to Fair Value0.00
Price to FCF―
Price to Operating Cash Flow208.50
PEG Ratio―
Income Statement
In the last 12 months, Procter & Gamble Health Ltd. had revenue of 12.46B and earned 3.13B in profits. Earnings per share was 188.29.
Revenue12.46B
Gross Profit6.84B
Operating Income4.02B
Pretax Income4.15B
Net Income3.13B
EBITDA4.38B
Earnings Per Share (EPS)188.29
Cash Flow
In the last 12 months, operating cash flow was 492.20M and capital expenditures -32.30M, giving a free cash flow of 459.90M billion.
Operating Cash Flow492.20M
Free Cash Flow459.90M
Free Cash Flow per Share27.71
Dividends & Yields
Procter & Gamble Health Ltd. pays an annual dividend of ₹45, resulting in a dividend yield of 2.27%
Dividend Per Share₹45
Dividend Yield2.27%
Payout Ratio69.97%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change22.92%
50-Day Moving Average5.91K
200-Day Moving Average5.41K
Relative Strength Index (RSI)58.13
Average Volume (3m)1.07K
Important Dates
Procter & Gamble Health Ltd. upcoming earnings date is Nov 5, 2025, TBA (Confirmed).
Last Earnings DateAug 1, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend DateAug 22, 2025
Financial Position
Procter & Gamble Health Ltd. as a current ratio of 2.44, with Debt / Equity ratio of 1.42%
Current Ratio2.44
Quick Ratio1.94
Debt to Market Cap0.00
Net Debt to EBITDA-0.41
Interest Coverage Ratio701.67
Taxes
In the past 12 months, Procter & Gamble Health Ltd. has paid 1.03B in taxes.
Income Tax1.03B
Effective Tax Rate0.25
Enterprise Valuation
Procter & Gamble Health Ltd. EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -1.08.
EV to Sales-0.15
EV to EBITDA-0.41
EV to Free Cash Flow-1.08
EV to Operating Cash Flow-1.03
Balance Sheet
Procter & Gamble Health Ltd. has ₹2.06B in cash and marketable securities with ₹76.20M in debt, giving a net cash position of -₹1.98B billion.
Cash & Marketable Securities₹2.06B
Total Debt₹76.20M
Net Cash-₹1.98B
Net Cash Per Share-₹119.55
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 63.08%, with operating margin of 32.30%, and net profit margin of 25.09%.
Gross Margin63.08%
Operating Margin32.30%
Pretax Margin33.36%
Net Profit Margin25.09%
EBITDA Margin35.19%
EBIT Margin33.40%
Analyst Forecast
The average price target for Procter & Gamble Health Ltd. is ₹7,160.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹7,160.00
Price Target Upside15.84% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast2.37%
EPS Growth Forecast23.22%